NCT06506591View on ClinicalTrials.gov

A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions

Healthy Participants

Interventions

DRUG

WD-890

Administered P.O.

DRUG

WD-890 Tablets Placebo

Administered P.O.

Trial Locations (1)

430056

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Zhejiang Wenda Medical Technology Co., Ltd.

OTHER

NCT06506591 - A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter